Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) FCF/Share TTM
The fcf/share ttm for Labcorp Holdings Inc. (LH) is $16.69 with a period-over-period change of +15.17%. Free cash flow per share divides trailing free cash flow by shares outstanding, showing cash generation per share.
LH FCF/Share TTM Chart
FCF/Share TTM History
| Date | FCF/Share TTM | % Change |
|---|---|---|
| Q1 2026 | $16.69 | +15.17% |
| Q4 2025 | $14.50 | (12.13%) |
| Q3 2025 | $16.50 | +9.95% |
| Q2 2025 | $15.00 | +9.79% |
| Q1 2025 | $13.67 | +4.99% |
| Q4 2024 | $13.02 | +30.28% |
| Q3 2024 | $9.99 | (1.18%) |
| Q2 2024 | $10.11 | +30.30% |
| Q1 2024 | $7.76 | (22.33%) |
| Q4 2023 | $9.99 | (10.53%) |
| Q3 2023 | $11.17 | (7.22%) |
| Q2 2023 | $12.03 | (15.16%) |
| Q1 2023 | $14.19 | (14.35%) |
| Q4 2022 | $16.56 | +1.10% |
| Q3 2022 | $16.38 | (18.58%) |
| Q2 2022 | $20.12 | +3.58% |
| Q1 2022 | $19.42 | (29.47%) |
| Q4 2021 | $27.54 | (3.71%) |
| Q3 2021 | $28.60 | (0.99%) |
| Q2 2021 | $28.88 | +4.65% |
| Q1 2021 | $27.60 | +54.71% |
| Q4 2020 | $17.84 | +15.13% |
| Q3 2020 | $15.49 | +28.94% |
| Q2 2020 | $12.02 | +9.15% |
| Q1 2020 | $11.01 | +3.29% |
| Q4 2019 | $10.66 | +8.33% |
| Q3 2019 | $9.84 | +28.22% |
| Q2 2019 | $7.67 | (12.22%) |
| Q1 2019 | $8.74 | +0.48% |
| Q4 2018 | $8.70 | (9.19%) |
| Q3 2018 | $9.58 | (10.74%) |
| Q2 2018 | $10.73 | +4.13% |
| Q1 2018 | $10.31 | (6.57%) |
| Q4 2017 | $11.03 | +8.86% |
| Q3 2017 | $10.13 | +9.58% |
| Q2 2017 | $9.25 | (3.09%) |
| Q1 2017 | $9.54 | +13.13% |
| Q4 2016 | $8.43 | +9.05% |
| Q3 2016 | $7.73 | (5.22%) |
| Q2 2016 | $8.16 | (5.95%) |
| Q1 2016 | $8.68 | +23.24% |
| Q4 2015 | $7.04 | +21.87% |
| Q3 2015 | $5.78 | +19.08% |
| Q2 2015 | $4.85 | +38.33% |
| Q1 2015 | $3.51 | (43.47%) |
| Q4 2014 | $6.21 | (3.67%) |
| Q3 2014 | $6.44 | (9.80%) |
| Q2 2014 | $7.14 | +13.31% |
| Q1 2014 | $6.30 | (9.73%) |
| Q4 2013 | $6.98 | +2.40% |
| Q3 2013 | $6.82 | +6.96% |
| Q2 2013 | $6.37 | (8.69%) |
| Q1 2013 | $6.98 | +0.03% |
| Q4 2012 | $6.98 | (6.33%) |
| Q3 2012 | $7.45 | +4.60% |
| Q2 2012 | $7.12 | +2.91% |
| Q1 2012 | $6.92 | (5.33%) |
| Q4 2011 | $7.31 | +8.63% |
| Q3 2011 | $6.73 | (0.21%) |
| Q2 2011 | $6.74 | (5.37%) |
| Q1 2011 | $7.13 | (5.68%) |
| Q4 2010 | $7.56 | +9.58% |
| Q3 2010 | $6.90 | (9.11%) |
| Q2 2010 | $7.59 | +3.98% |
| Q1 2010 | $7.30 | +5.58% |
| Q4 2009 | $6.91 | +1.66% |
| Q3 2009 | $6.80 | +11.33% |
| Q2 2009 | $6.11 | +0.20% |
| Q1 2009 | $6.09 | +7.13% |
| Q4 2008 | $5.69 | (2.08%) |
| Q3 2008 | $5.81 | +11.02% |
| Q2 2008 | $5.23 | +6.89% |
| Q1 2008 | $4.90 | +1.16% |
| Q4 2007 | $4.84 | +21.27% |
| Q3 2007 | $3.99 | (5.42%) |
| Q2 2007 | $4.22 | +4.78% |
| Q1 2007 | $4.03 | (2.78%) |
| Q4 2006 | $4.14 | +5.20% |
| Q3 2006 | $3.94 | (4.16%) |
| Q2 2006 | $4.11 | +8.19% |
| Q1 2006 | $3.80 | +5.38% |
| Q4 2005 | $3.60 | +25.46% |
| Q3 2005 | $2.87 | +6.42% |
| Q2 2005 | $2.70 | (12.50%) |
| Q1 2005 | $3.08 | (3.79%) |
| Q4 2004 | $3.21 | (4.53%) |
| Q3 2004 | $3.36 | (2.23%) |
| Q2 2004 | $3.43 | +5.67% |
| Q1 2004 | $3.25 | (4.78%) |
| Q4 2003 | $3.41 | +6.61% |
| Q3 2003 | $3.20 | +8.75% |
| Q2 2003 | $2.94 | +7.85% |
| Q1 2003 | $2.73 | - |
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter